Current Metabolomics
Title:Meet Our Editor
Volume: 3 Issue: 1
Author(s): Robert Powers
Affiliation:
Export Options
About this article
Cite this article as:
Powers Robert, Meet Our Editor, Current Metabolomics 2015; 3 (1) . https://dx.doi.org/10.2174/2213235X0303150511123451
DOI https://dx.doi.org/10.2174/2213235X0303150511123451 |
Print ISSN 2213-235X |
Publisher Name Bentham Science Publisher |
Online ISSN 2213-2368 |
20
Related Articles
-
Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity
Current Pharmaceutical Design Crosstalk between Gut Microbiota and the Central Nervous System in Multiple Sclerosis: Strengths, Weaknesses, Opportunities and Threats Analysis of the Use of An Experimental Model
CNS & Neurological Disorders - Drug Targets Pedometer-Based Walking Interventions for Free-Living Adults with Type 2 Diabetes: A Systematic Review
Current Diabetes Reviews Knock-out and Knock-in Mice to Investigate the Role of Nicotinic Receptors in the Central Nervous System
Current Drug Targets - CNS & Neurological Disorders Nanochemistry-Based Immunotherapy for HIV-1
Current Medicinal Chemistry Medical Implications of Benzimidazole Derivatives as Drugs Designed for Targeting DNA and DNA Associated Processes
Current Medicinal Chemistry Global Account of Barriers and Facilitators of Physical Activity Among Patients with Diabetes Mellitus: A Narrative Review of the Literature
Current Diabetes Reviews Objective Biological Measures for the Assessment and Management of Auditory Processing Disorder
Current Pediatric Reviews Nanomedicine for Intranasal Delivery to Improve Brain Uptake
Current Drug Delivery Decreased Vascular Repair and Neovascularization with Ageing: Mechanisms and Clinical Relevance with an Emphasis on Hypoxia- Inducible Factor-1
Current Molecular Medicine Ion Channels on Microglia: Therapeutic Targets for Neuroprotection
CNS & Neurological Disorders - Drug Targets Progress in the Discovery of BACE Inhibitors
Current Pharmaceutical Design Treatment of Atopic Dermatitis: Current Status and Future Prospects
Current Drug Therapy Default Mode, Executive Function, and Language Functional Connectivity Networks are Compromised in Mild Alzheimer´s Disease
Current Alzheimer Research Therapeutic Use of Vitamin D and its Analogues in Autoimmunity
Recent Patents on Inflammation & Allergy Drug Discovery How Does Indoleamine 2,3-Dioxygenase Contribute to HIV-Mediated Immune Dysregulation
Current Drug Metabolism Treatment of Refractory Autoimmune Diseases with Ablative Immunotherapy Using Monoclonal Antibodies and / or High Dose Chemotherapy with Hematopoietic Stem Cell Support
Current Pharmaceutical Design Traditional Chinese Medicine Network Pharmacology in Cardiovascular Precision Medicine
Current Pharmaceutical Design Peripheral Corticotropin Releasing Factor Signaling Inhibits Gastric Emptying: Mechanisms of Action and Role in Stress-related Gastric Alterations of Motor Function
Current Pharmaceutical Design Liposomes: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design